<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01206946</url>
  </required_header>
  <id_info>
    <org_study_id>PED.KY.11</org_study_id>
    <nct_id>NCT01206946</nct_id>
  </id_info>
  <brief_title>Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants</brief_title>
  <official_title>Effect of Antenatal Steroids for Women at Risk of Late Preterm Delivery on Neonatal Respiratory Morbidity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American University of Beirut Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>American University of Beirut Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of the study is that administration of antenatal steroid to women at high risk
      of preterm birth after 34 weeks of gestation would reduce the risk of respiratory
      complications, specifically Respiratory Distress Syndrome (RDS) or Transient Tachypnea of the
      Newborn (TTN) in late preterm babies.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">September 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory Distress Syndrome (RDS)or Transient Tachypnea of the Newborn(TTN)</measure>
    <time_frame>First three days of life</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Admission to NICU</measure>
    <time_frame>First three days of life</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>Neonatal period (28 days of life)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days on oxygen</measure>
    <time_frame>Neonatal period (28 days of life)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intubations</measure>
    <time_frame>First three days of life</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surfactant treatment</measure>
    <time_frame>First three days of life</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pneumothorax</measure>
    <time_frame>First three days of life</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Pulmonary Hypertension of the Newborn(PPHN)</measure>
    <time_frame>First three days of life</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days on ventilation</measure>
    <time_frame>Neonatal period (28 days of life)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necrotizing enterocolitis (NEC)</measure>
    <time_frame>Neonatal period (28 days of life)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical sepsis</measure>
    <time_frame>Neonatal period (28 days of life)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraventricular Hemorrhage (IVH)</measure>
    <time_frame>First week after birth</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Respiratory Distress Syndrome, Newborn</condition>
  <condition>Transient Tachypnea of the Newborn</condition>
  <arm_group>
    <arm_group_label>Antenatal steroids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Betamethasone</intervention_name>
    <description>A single course of betamethasone (two doses of 12 mg/dose given at 24 hourly intervals)</description>
    <arm_group_label>Antenatal steroids</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>Two doses of 2ml of normal saline given at 24 hourly intervals</description>
    <arm_group_label>Normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women between 34 0/7- 36 6/7 weeks of gestation

          -  High risk of preterm birth

        Exclusion Criteria:

          -  Multiple births

          -  Fetal congenital malformations

          -  A course of steroids within 2 weeks of randomization

          -  Multiple courses of steroids

          -  Chorioamnionitis

          -  Non reassuring fetal heart rate

          -  Obstetrical indication of delivery

          -  Active bleeding

          -  Pregnancy related hypertensive disorders

          -  Uncontrolled diabetes
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khalid Yunis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>American University of Beirut Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Khalid Yunis, MD</last_name>
    <phone>961-1-350000</phone>
    <phone_ext>5538</phone_ext>
    <email>kayunis@aub.edu.lb</email>
  </overall_contact>
  <location>
    <facility>
      <name>American University of Beirut Medical Center</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Khalid Yunis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lama Charafeddine, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ziyad Mahfoud, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anwar Nassar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bahman Hospital</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ali Zaytoun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Iman Charara, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hotel Dieu de France</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Imad Melki, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elie Atiyeh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rafik Hariri University Hospital</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Hassan Fakhoury, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zoulfikar Hachach, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Georges Hospital- University Medical Center</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Georged El Kehdy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dany Hamod, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Lebanon</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2010</study_first_submitted>
  <study_first_submitted_qc>September 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2010</study_first_posted>
  <last_update_submitted>June 22, 2011</last_update_submitted>
  <last_update_submitted_qc>June 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Khalid Yunis</name_title>
    <organization>American University of Beirut Medical Center</organization>
  </responsible_party>
  <keyword>Respiratory distress</keyword>
  <keyword>Antenatal steroids</keyword>
  <keyword>late preterm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Tachypnea</mesh_term>
    <mesh_term>Transient Tachypnea of the Newborn</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Betamethasone benzoate</mesh_term>
    <mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
    <mesh_term>Betamethasone</mesh_term>
    <mesh_term>Betamethasone Valerate</mesh_term>
    <mesh_term>Betamethasone sodium phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

